A practical reference on bremelanotide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-08-15 and is reviewed periodically as new material appears.
Bremelanotide is a synthetic cyclic heptapeptide developed under the research code PT-141. The code reflects its position in an internal compound series rather than a chemical classification, and the name bremelanotide was later adopted for regulatory filings. Structurally it belongs to the melanocortin peptide family and shares a core sequence motif with alpha-melanocyte-stimulating hormone. The compound is supplied as an acetate salt in aqueous solution for injection. In reference literature it is indexed under both the code and the generic name, a dual listing that can complicate database searches.
Early work on melanocortin analogs in the 1980s and 1990s produced peptides intended to influence pigmentation and appetite. One of these, melanotan II, was observed to affect sexual desire as an incidental finding in self-administration reports. Researchers then pursued analogs with altered receptor selectivity and improved handling characteristics, and PT-141 emerged from that program in the late 1990s. The development path moved from dermatology and metabolism toward a central nervous system application, a shift that shaped both trial designs and the eventual label.
Lyophilised peptide is generally held below minus twenty degrees Celsius, protected from light and moisture, because hydrolysis and oxidation accumulate faster at ambient temperature. Once reconstituted, solutions are typically kept between two and eight degrees Celsius and used within a short window defined by the supplier. Repeated freeze-thaw cycles are avoided since they promote aggregation and loss of soluble material. Container material matters as well, because peptides adsorb to certain plastics and glass surfaces at low concentration. Stability figures supplied by a vendor apply only to the specific lot and buffer that were tested.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography combined with mass spectrometry. A gradient of water and acetonitrile containing trifluoroacetic acid is a common mobile phase, and ultraviolet detection near 214 nanometres responds to the peptide backbone. Mass spectrometry confirms the expected molecular mass and helps reveal truncation or oxidation products. Purity is reported as a peak-area percentage, a figure that depends on the wavelength and gradient used, so values from different laboratories are not always directly comparable. Peptide mapping and amino acid analysis provide additional confirmation when required.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H68N14O10 | Cyclic heptapeptide core |
| Molecular weight | 1025.2 g/mol | Calculated for the free base |
| CAS registry number | 189691-06-3 | Free base; the acetate salt has a separate entry |
| Solubility class | Water-soluble | Freely soluble in aqueous media near neutral pH |
| Typical storage | 2 to 8 °C | Protect from light; avoid repeated freeze-thaw cycles |
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
Published discussion sits at the intersection of peptide chemistry, neuroendocrinology and sexual medicine. Trial reports emphasise change scores on validated instruments, while mechanistic papers focus on hypothalamic circuits and receptor selectivity. Because placebo response in this field is large, effect sizes are usually reported with confidence intervals rather than as isolated averages. Reviews note that female and male data sets are not interchangeable and should be read separately. Diagnostic terminology has been revised over time, which complicates comparison between older and newer studies.
PT-141 initiates cellular signaling by binding to specific subtypes within the melanocortin receptor family. These receptors belong to the G protein-coupled receptor superfamily, and activation raises intracellular cyclic adenosine monophosphate levels. This cascade ultimately influences neuronal circuits in the central nervous system that are associated with sexual desire and arousal. Research indicates the compound's action concentrates in hypothalamic regions rather than peripheral tissues, which helps explain some observed pharmacological features. The selectivity of receptor binding underlies its functional differences.
Compared with the related compound melanotan II, PT-141 shows markedly weaker activation of receptors tied to pigmentation. This difference stems from subtle structural variations that alter affinity distribution across receptor subtypes. Investigators propose that such selectivity produces a different side effect profile in specific applications. However, downstream consequences of prolonged receptor activation remain uncertain in the literature. Published studies do not fully agree on the duration of signaling pathway activity and the mechanisms of desensitization.
From a pharmacokinetic standpoint, the peptide is usually delivered by injection because oral bioavailability is very low; proteases in the digestive tract degrade it rapidly. After subcutaneous administration, plasma concentrations reach a peak within roughly one hour. Its elimination half-life is relatively short, with most reports placing it in the range of a few hours. Nasal formulations have also been examined, though absorption varies widely between individuals. Metabolism proceeds mainly through peptidase cleavage, and the resulting products are excreted by the kidneys.
== Side effects == Common side effects of anastrozole (≥10% incidence) include hot flashes, asthenia, arthritis, pain, arthralgia, hypertension, depression, nausea and vomiting, rash, osteoporosis, bone fractures, back pain, insomnia, headache, bone pain, peripheral edema, coughing, dyspnea, pharyngitis, and lymphedema. Serious but rare adverse effects (<0.1% incidence) include skin reactions such as lesions, ulcers, or blisters; allergic reactions with swelling of the face, lips, tongue, and/or throat that may cause difficulty swallowing or breathing; and abnormal liver function tests as well as hepatitis.
=== Creationism === Crick was a firm critic of young Earth creationism. In the 1987 United States Supreme Court case Edwards v. Aguillard, Crick joined a group of other Nobel laureates who advised, "'Creation-science' simply has no place in the public-school science classroom." Crick was also an advocate for the establishment of Darwin Day as a British national holiday.
April 27, 1999, A small fan site known as contaminated.net is relaunched as "Planet Half-Life", covering Half-Life and editing resources. November 16, 1999, Major changes to layout and color scheme, plus new sections covering Half-Life: Opposing Force and the announcement of Half-Life 2. December 3, 2000, New sections covering Counter-Strike and Team Fortress Classic. June 19, 2001, New section covering Half-Life: Blue Shift. September 14, 2002, New section covering Day of Defeat. May 24, 2003, Half-Life 2 section re-opens amid rumors of a September 2003 launch and early media releases. July 17, 2003, Major changes to color scheme and graphics in anticipation of Half-Life 2 launch. June 11, 2006, PHLWiki is launched, with bulk of content made up by staff writers prior to public unveiling. September 13, 2006, Complete site format change to accommodate new PNAP article submission system, as well as new color scheme and graphics that were used until the absence of site updating. September 13, 2007, PHL Steam Community officially announced to the public. August 13, 2012, Last entry posted.
Sources: en.wikipedia.org
=== Transport to the brain === Vitamin C does not pass from the bloodstream into the brain, although the brain is one of the organs that have the greatest concentration of vitamin C. Instead, DHA is transported through the blood–brain barrier via GLUT1 transporters, and then reduced back to ascorbic acid.
In traditional amphetamine pharmacology, TAAR1 activation triggers intracellular phosphorylation signaling cascades that facilitate and optimize the structural reversal of monoamine transporters (MATs) to allow efficient neurotransmitter efflux. Because cathinones fail to activate TAAR1, this phosphorylation is absent, rendering carrier-mediated efflux less efficient. Consequently, displaced neurotransmitters tend to accumulate and linger within the cytoplasm rather than being cleanly exported to the synaptic cleft, promoting intracellular auto-oxidation, and faster depletion. Psychostimulants differ in their relative affinity for DAT, SERT and NET. In a study done on brain cells of male rats 3-CMC was found to interact on a relatively similar level with DAT and NET as mephedrone, while it interacts significantly less with SERT. Another study done on male rats also concludes that 3-CMC causes more release of dopamine in proportion to serotonin whereas mephedrone releases relatively more serotonin. 3-CMC produces hyperlocomotion, a psychostimulant-like effect, in rodents. It substitutes for cocaine in drug discrimination tests in monkeys. The drug is less potent in substituting for cocaine than methcathinone, which has been theorized to be due to its greater capacity to induce serotonin release and to thereby inhibit its own reinforcing effects.
If two vertices have the same mass difference of one or several amino acids, a directed edge will be applied. The SeqMS algorithm, Lutefisk algorithm, Sherenga algorithm are some examples of this type.
== Extraterrestrial occurrence == Following the Mars flyby of the Mariner 4 spacecraft in 1966, scientists concluded that Mars' polar caps consist entirely of dry ice. However, findings made in 2003 by researchers at the California Institute of Technology have shown that Mars' polar caps are almost completely made of water ice, and that dry ice only forms a thin surface layer that thickens and thins seasonally. A phenomenon named dry ice storms was proposed to occur over the polar regions of Mars. They are comparable to Earth's thunderstorms, with crystalline CO2 taking the place of water in the clouds. Dry ice is also proposed as a mechanism for the geysers on Mars. In 2012, the European Space Agency's Venus Express probe detected a cold layer in the atmosphere of Venus where temperatures are close to the triple point of carbon dioxide –hence it is possible that flakes of dry ice precipitate. Observations from the Uranus flyby by Voyager 2 indicates that dry ice is present on the surface of its large moons Ariel, Umbriel and Titania. Scientists speculate that the magnetic field of Uranus contributes to the generation of CO2 ice on the surfaces of its moons. Voyager 2 observations of Neptune's moon Triton suggested the presence of dry ice on the surface, though followup observations indicate that the carbon ices on the surface are carbon monoxide but that the moon's crust is composed of a significant quantity of dry ice.
Sources: en.wikipedia.org
=== Vas deferens === The vas deferens can grow back together after a vasectomy–thus resulting in vasectomy failure. This occurs due to the fact that the epithelium of the vas deferens, similar to the epithelium of some other human body parts, is capable of regenerating and creating a new tube in the event that the vas deferens is damaged and/or severed. Even when as much as five centimeters, or two inches, of the vas deferens is removed, the vas deferens can still grow back together and become reattached–thus allowing sperm to once again pass and flow through the vas deferens, restoring one's fertility.
Sources Ortlepp, Anke (2017). Jim Crow Terminals: The Desegregation of American Airports. The University of Georgia Press. ISBN 9780820351216. Wells, Donald R. (January 1981). "A history of air transportation in Memphis". Mid-South Business Journal. I (1). ISSN 0279-8174.
=== Flavor and Color === The juice of the uppermost parts of the plant has an intensive green color; its pure flavor is bitter – hempy. The juice of the fibers and shives of the plant is lighter in color and tastes sweet. Hemp juice creates a distinct umami flavor, based on the multitude of proteins, polyphenols and cannabinoids in the hemp plant. The bitter taste of the hemp juice is transformed into a fresh and sweet flavor after mixing it with vegetable or fruit juices. Moreover, the original taste of fruits and vegetables may be highlighted with the use of hemp juice.
Sources: en.wikipedia.org
PT-141 was the internal development code assigned to bremelanotide during preclinical research. Reference sources sometimes index the peptide under the code rather than the generic name. The two terms describe the same molecule.
They are related but distinct cyclic peptides. Melanotan II is an earlier and less selective melanocortin analog. Bremelanotide was developed later with a narrower receptor profile and a defined clinical application.
The reviewed product is given by subcutaneous injection using a single-use autoinjector. Administration occurs under prescription supervision. The device delivers one fixed amount per use rather than a measured or adjustable quantity.
Purity is normally expressed as a percentage of total peak area from a chromatographic run. The value depends on the column, gradient and detection wavelength chosen. Results generated under different conditions are therefore not always interchangeable.